LBRX (LB Pharmaceuticals) Insider Ownership: 0.06 % (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LBRX LB Pharmaceuticals Inc LBRX
12 GF Score
Price $35.26
! 1 Warning Sign
View Full Analysis

What is LB Pharmaceuticals Insider Ownership?

LB Pharmaceuticals LBRX +9.11% 12 Insider Ownership is 0.06 % as of Jul. 22, 2026. GuruFocus rates LBRX with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, LB Pharmaceuticals's insider ownership is 0.06%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, LB Pharmaceuticals's Institutional Ownership is 102.43%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, LB Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 83.11%.

LB Pharmaceuticals Insider Ownership Historical Data

* Premium members only.

The historical data trend for LB Pharmaceuticals's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LB Pharmaceuticals Insider Ownership Chart

LB Pharmaceuticals Historical Data

The historical data trend for LB Pharmaceuticals can be seen below:

2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30
Insider Ownership 0.08 0.08 0.07 0.07 0.07 0.06 0.06
LBRX
12GF Score
LB Pharmaceuticals Inc LBRX
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LB Pharmaceuticals Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.06 % mean?
LB Pharmaceuticals (LBRX) has a Insider Ownership of 0.06 % as of Jul. 22, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on LB Pharmaceuticals and its competitors.
Is LB Pharmaceuticals' Insider Ownership too high?
LB Pharmaceuticals' current Insider Ownership is 0.06 %. Overall, LB Pharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does LB Pharmaceuticals' Insider Ownership compare to MRVI and SLDB?
LB Pharmaceuticals' Insider Ownership of 0.06 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on LB Pharmaceuticals and its competitors. LB Pharmaceuticals's current Insider Ownership is 0.06 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LB Pharmaceuticals stock overvalued right now?
LB Pharmaceuticals (LBRX) has a current Insider Ownership of 0.06 %. The current Insider Ownership is 0.06 %. LB Pharmaceuticals' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For LB Pharmaceuticals (LBRX), the current Insider Ownership is 0.06 % as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LB Pharmaceuticals Business Description

Address One Pennsylvania Plaza, Suite 1025, New York, NY, USA, 10119
LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases. It is building a pipeline that leverages the broad therapeutic potential of its product candidate, LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is currently in late-stage clinical development for schizophrenia and bipolar depression. The company operates as a single reportable segment in the development of novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.
12GF Score

Get the complete analysis for LBRX

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$35.26
Price